- Home
- BYRN vs TKNO Comparison
BYRN vs TKNO Comparison
Compare BYRN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYRN
- TKNO
- Stock Information
- Founded
- BYRN 2005
- TKNO 1996
- Country
- BYRN United States
- TKNO United States
- Employees
- BYRN N/A
- TKNO N/A
- Industry
- BYRN Industrial Machinery/Components
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- BYRN Miscellaneous
- TKNO Health Care
- Exchange
- BYRN Nasdaq
- TKNO Nasdaq
- Market Cap
- BYRN 670.5M
- TKNO 356.4M
- IPO Year
- BYRN N/A
- TKNO 2021
- Fundamental
- Price
- BYRN $23.29
- TKNO $4.81
- Analyst Decision
- BYRN Strong Buy
- TKNO Buy
- Analyst Count
- BYRN 2
- TKNO 1
- Target Price
- BYRN $41.50
- TKNO $5.00
- AVG Volume (30 Days)
- BYRN 721.6K
- TKNO 311.3K
- Earning Date
- BYRN 07-10-2025
- TKNO 08-12-2025
- Dividend Yield
- BYRN N/A
- TKNO N/A
- EPS Growth
- BYRN N/A
- TKNO N/A
- EPS
- BYRN 0.62
- TKNO N/A
- Revenue
- BYRN $103,528,000.00
- TKNO $38,250,000.00
- Revenue This Year
- BYRN $37.49
- TKNO $8.73
- Revenue Next Year
- BYRN $21.56
- TKNO $16.53
- P/E Ratio
- BYRN $40.81
- TKNO N/A
- Revenue Growth
- BYRN 73.56
- TKNO 3.79
- 52 Week Low
- BYRN $7.79
- TKNO $1.18
- 52 Week High
- BYRN $34.78
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- BYRN 34.42
- TKNO 35.41
- Support Level
- BYRN $31.35
- TKNO $4.90
- Resistance Level
- BYRN $34.30
- TKNO $5.38
- Average True Range (ATR)
- BYRN 2.52
- TKNO 0.33
- MACD
- BYRN -0.96
- TKNO 0.01
- Stochastic Oscillator
- BYRN 2.42
- TKNO 13.41
About BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.